GB0123991D0 - New therapeutic use - Google Patents

New therapeutic use

Info

Publication number
GB0123991D0
GB0123991D0 GBGB0123991.2A GB0123991A GB0123991D0 GB 0123991 D0 GB0123991 D0 GB 0123991D0 GB 0123991 A GB0123991 A GB 0123991A GB 0123991 D0 GB0123991 D0 GB 0123991D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic use
new therapeutic
new
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0123991.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ARACHNOVA Ltd
Original Assignee
ARACHNOVA Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ARACHNOVA Ltd filed Critical ARACHNOVA Ltd
Priority to GBGB0123991.2A priority Critical patent/GB0123991D0/en
Publication of GB0123991D0 publication Critical patent/GB0123991D0/en
Priority to PCT/GB2002/004501 priority patent/WO2003030903A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0123991.2A 2001-10-05 2001-10-05 New therapeutic use Ceased GB0123991D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0123991.2A GB0123991D0 (en) 2001-10-05 2001-10-05 New therapeutic use
PCT/GB2002/004501 WO2003030903A1 (en) 2001-10-05 2002-10-04 The use of tizanidine for treating metabolic disorders related to abnormal insulin secretion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0123991.2A GB0123991D0 (en) 2001-10-05 2001-10-05 New therapeutic use

Publications (1)

Publication Number Publication Date
GB0123991D0 true GB0123991D0 (en) 2001-11-28

Family

ID=9923329

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0123991.2A Ceased GB0123991D0 (en) 2001-10-05 2001-10-05 New therapeutic use

Country Status (2)

Country Link
GB (1) GB0123991D0 (en)
WO (1) WO2003030903A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006206274A1 (en) * 2005-01-20 2006-07-27 Sirtris Pharmaceuticals, Inc. Use of sirtuin-activating compounds for treating flushing and drug induced weight gain
WO2008014299A2 (en) * 2006-07-27 2008-01-31 Allergan, Inc. Use of an alpha2-agonist composition for the treatment of hyperlipidemia

Also Published As

Publication number Publication date
WO2003030903A1 (en) 2003-04-17

Similar Documents

Publication Publication Date Title
EP1463438A4 (en) Endomural therapy
GB0119152D0 (en) Therapeutic agents
GB0113841D0 (en) Therapeutic agents
GB0128885D0 (en) Therapeutic agents
GB0120347D0 (en) Therapeutic agents
GB0114867D0 (en) Therapeutic agents
GB0117060D0 (en) Therapeutic agents
GB0108930D0 (en) Therapeutic agents
GB0113839D0 (en) Therapeutic agents
GB0113842D0 (en) Therapeutic agents
GB0111191D0 (en) Therapeutic agents
GB0113843D0 (en) Therapeutic agents
GB0123991D0 (en) New therapeutic use
GB0108982D0 (en) Therapeutic agents
GB0119803D0 (en) Therapeutic agents
GB0120345D0 (en) Therapeutic agents
GB0128122D0 (en) Therapeutic use
GB0119828D0 (en) Therapeutic agents
GB0119462D0 (en) New therapeutic use
GB0128304D0 (en) New therapeutic use
GB0128300D0 (en) New therapeutic use
GB0112491D0 (en) New therapeutic use
GB0110585D0 (en) New therapeutic use
GB0110584D0 (en) New therapeutic use
GB0107114D0 (en) New therapeutic use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)